GNPX

Genprex, Inc. - Common Stock (GNPX)

About Genprex, Inc. - Common Stock (GNPX)

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.

Details

Daily high

$3.54

Daily low

$3.22

Price at open

$3.49

52 Week High

$63.00

52 Week Low

$2.61

Market cap

7.8M

Dividend yield

0.00%

Volume

300,800

Avg. volume

374,608

P/E ratio

-.07

Genprex, Inc. - Common Stock News